Posts by John

Vivani Medical targets August for human trials of its new semaglutide implant. Learn how this novel delivery system could revolutionize metabolic care.

A major study by Stanford and Harvard experts ranks Doximity as a leader in clinical AI safety, highlighting critical gaps in current healthcare technology.

The FAST-02 clinical trial confirms that rapid, targeted radiation therapy provides significant pain relief for patients with chest wall bone metastases.

Researchers have launched a clinical trial to evaluate a specialized yoga program for early-stage Parkinson’s disease, aiming to improve motor function.

The WHO has launched a clinical trial for Gilead’s obeldesivir to treat the Bundibugyo Ebola virus, marking a key step in developing new viral therapies.

BlueCross BlueShield of Tennessee updates medical policies for FibroScan and noninvasive elastography. Learn what this means for liver disease diagnosis.

The FDA has issued final guidance for clinical trials involving psychedelic drugs, setting new standards for safety, trial design, and patient monitoring.

A Phase 1b clinical trial explores a new short-lived anti-PD-L1 antibody treatment for Alzheimer’s disease, targeting neuro-inflammation and plaque clearance.

A new malaria drug candidate has cleared Phase I clinical trials with positive safety results, offering fresh hope against drug-resistant parasites.

Maxona Pharmaceuticals earns FDA clearance for the Phase 2 clinical trial of MAX-001, a novel non-opioid treatment for acute pain management.